AMGEN INC Cash And Cash Equivalents At Carrying Value

• AMGEN INC showed a decrease of -23.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from AMGEN INC's annual report (Form 10-K), filed with the SEC on February 13, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 18 years of available data (2008 to 2025), AMGEN INC's Cash And Cash Equivalents At Carrying Value has grown by 414.6%.
• Historical annual values: Fiscal year 2025: $9.13 billion | Fiscal year 2024: $11.97 billion | Fiscal year 2023: $10.94 billion | Fiscal year 2022: $7.63 billion | Fiscal year 2021: $7.99 billion | Fiscal year 2020: $6.27 billion | Fiscal year 2019: $6.04 billion | Fiscal year 2018: $6.95 billion | Fiscal year 2017: $3.80 billion | Fiscal year 2016: $3.24 billion | Fiscal year 2015: $4.14 billion | Fiscal year 2014: $3.73 billion | Fiscal year 2013: $3.81 billion | Fiscal year 2012: $3.26 billion | Fiscal year 2011: $6.95 billion | Fiscal year 2010: $3.29 billion | Fiscal year 2009: $2.88 billion | Fiscal year 2008: $1.77 billion.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026